Concourse Financial Group Securities’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $8.34K | Hold |
|
|||||
|
2024
Q3 | $7.21K | Hold |
|
|||||
|
2024
Q2 | $6.07K | Hold |
|
|||||
|
2024
Q1 | $5.26K | Hold |
|
|||||
|
2023
Q4 | $5.14K | Hold |
|
|||||
|
2023
Q3 | $4.31K | Hold |
|
|||||
|
2023
Q2 | $5.19K | Sell |
|
|||||
|
2023
Q1 | $6.4K | Hold |
|
|||||
|
2022
Q4 | $5.81K | Sell |
|
|||||
|
2022
Q3 | $7K | Hold |
|
|||||
|
2022
Q2 | $8K | Hold |
|
|||||
|
2022
Q1 | $10K | Hold |
|
|||||
|
2021
Q4 | $13K | Hold |
|
|||||
|
2021
Q3 | $12K | Hold |
|
|||||
|
2021
Q2 | $11K | Hold |
|
|||||
|
2021
Q1 | $13K | Hold |
|
|||||
|
2020
Q4 | $9K | Hold |
|
|||||
|
2020
Q3 | $8K | Hold |
|
|||||
|
2020
Q2 | $10K | Sell |
|
|||||
|
2020
Q1 | $16K | Sell |
|
|||||
|
2019
Q4 | $29K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $2K | Sell |
|
|||||
|
2019
Q1 | $15K | Sell |
|
|||||
|
2018
Q4 | $20K | Buy |
|
|||||
|
2018
Q3 | $11K | Buy |
|